CreativeOne Wealth’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.21M Sell
221,327
-58,665
-21% -$1.56M 0.14% 129
2025
Q4
$6.97M Buy
279,992
+29,010
+12% +$732K 0.17% 110
2025
Q3
$6.4M Buy
250,982
+15,724
+7% +$388K 0.16% 120
2025
Q2
$5.7M Buy
235,258
+56,745
+32% +$1.32M 0.15% 135
2025
Q1
$4.52M Buy
178,513
+42,949
+32% +$1.12M 0.14% 151
2024
Q4
$3.6M Buy
135,564
+17,891
+15% +$485K 0.11% 173
2024
Q3
$3.41M Buy
117,673
+45,163
+62% +$1.32M 0.12% 167
2024
Q2
$2.03M Sell
72,510
-1,683
-2% -$46.3K 0.1% 193
2024
Q1
$2.06M Buy
74,193
+45,882
+162% +$1.27M 0.08% 226
2023
Q4
$815K Sell
28,311
-32,478
-53% -$982K 0.05% 280
2023
Q3
$2.02M Sell
60,789
-32,847
-35% -$1.16M 0.15% 140
2023
Q2
$3.44M Buy
93,636
+31,061
+50% +$1.21M 0.16% 108
2023
Q1
$2.55M Buy
62,575
+10,374
+20% +$448K 0.13% 136
2022
Q4
$2.67M Buy
52,201
+4,453
+9% +$213K 0.15% 123
2022
Q3
$2.09M Buy
47,748
+18,079
+61% +$879K 0.13% 142
2022
Q2
$1.55M Sell
29,669
-1,860
-6% -$94.8K 0.08% 194
2022
Q1
$1.63M Sell
31,529
-4,725
-13% -$245K 0.08% 197
2021
Q4
$2.14M Sell
36,254
-5,415
-13% -$268K 0.11% 174
2021
Q3
$1.79M Sell
41,669
-18,796
-31% -$833K 0.11% 165
2021
Q2
$2.37M Buy
60,465
+25,290
+72% +$983K 0.15% 130
2021
Q1
$1.27M Buy
35,175
+9,045
+35% +$321K 0.1% 175
2020
Q4
$962K Buy
+26,130
New +$958K 0.08% 190
2019
Q3
Sell
-4,990
Closed -$205K 189
2019
Q2
$205K Buy
+4,990
New +$198K 0.04% 169

Other funds holding PFE

CreativeOne Wealth's PFE Position: Q1 2026 in Review

CreativeOne Wealth reduced its Pfizer (PFE) stake by 21% in Q1 2026, selling an estimated $1.56M and leaving 221,327 shares worth $6.21M. The position accounts for 0.14% of the portfolio, ranked #129.

CreativeOne Wealth first reported a position in PFE in Q2 2019 and has held it in 23 quarters since. The position peaked at $6.97M in Q4 2025. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • CreativeOne Wealth held 221,327 shares of Pfizer worth $6.21M as of Q1 2026.
  • CreativeOne Wealth sold 58,665 Pfizer shares in Q1 2026, an estimated $1.56M.
  • Pfizer made up 0.14% of CreativeOne Wealth's portfolio in Q1 2026, its #129 holding.
  • CreativeOne Wealth first reported a position in Pfizer in Q2 2019 and has held it in 23 quarters since.
  • CreativeOne Wealth's Pfizer position peaked at $6.97M in Q4 2025.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on CreativeOne Wealth's 13F filing for Q1 2026, filed 15 May 2026.